Asia-Pacific’s medical devices industry saw a drop of 28.57% in deal activity during September 2021, when compared with the last 12-month average, led by Honghui Capital, Qingchi Capital, Sanzheng Health Investment, Sequoia Capital China Fund, Sherpa Investment, SongHe Capital and Temasek Holdings (HK)’s $100m venture financing deal with Shanghai Aikangte Medical Technology, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 25 medical devices industry deals worth $307m were announced for the region in September 2021, against the 12-month average of 35 deals.

Of all the deal types, venture financing saw most activity in September 2021 with 17 transactions, representing a 68% share for the region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In second place was M&A with seven deals, followed by private equity deals with one transactions, respectively capturing a 28% and 4% share of the overall deal activity for the month.

In terms of value of deals, venture financing was the leading category in Asia-Pacific’s medical devices industry with $234.49m, while M&A and private equity deals totalled $58.8m and $13.68m, respectively.

Asia-Pacific medical devices industry deals in September 2021: Top deals

The top five medical devices deals accounted for 79.9% of the overall value during September 2021.

The combined value of the top five medical devices deals stood at $245.22m, against the overall value of $307m recorded for the month.

The top five medical devices industry deals of September 2021 tracked by GlobalData were:

1) Honghui Capital,Qingchi Capital,Sanzheng Health Investment,Sequoia Capital China Fund,Sherpa Investment,SongHe Capital and Temasek Holdings (HK) $100m venture financing deal with Shanghai Aikangte Medical Technology

2) The $53.8m acquisition of 80.3% stake in Strand Life Sciences by Reliance Strategic Business Ventures

3) CSIRO Financial Services,Horizons Ventures and JAADE Australian Private Assets Fund $45m venture financing deal with Prospection

4) The $30.94m venture financing of Chengdu Hanchen Guangyi Technology by Beijing Junlian Capital Management,Chengdu Boyuan Investment Management,Innovation Works (China),LYFE Capital,Northern Light Venture Capital and Yunzhi Capital

5) Eight Roads Ventures China,MSA Capital,Quan Capital and Sequoia China Fund $15.48m venture financing deal with Nanjing Suikun Intelligent Technology